SCM
AVXL icon

Sterling Capital Management’s Anavex Life Sciences AVXL Stock Holding History

Sterling Capital Management’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.15K Buy
1,604
+1,043
+186% +$3.09K ﹤0.01% 2715
2026
Q1 		$1.72K Hold
561
– – ﹤0.01% 3020
2025
Q4 		$2K Buy
561
+358
+176% +$2.19K ﹤0.01% 3065
2025
Q3 		$1.81K Buy
203
+1
+0.5% +$10 ﹤0.01% 2995
2025
Q2 		$1.86K Sell
202
-771
-79% -$6.58K ﹤0.01% 2935
2025
Q1 		$8.35K Sell
973
-816
-46% -$7.71K ﹤0.01% 1926
2024
Q4 		$19.2K Buy
1,789
+1,599
+842% +$12.3K ﹤0.01% 1888
2024
Q3 		$1.08K Buy
+190
New +$1.1K ﹤0.01% 2481

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Sterling Capital Management's AVXL Position: Q2 2026 in Review

Sterling Capital Management increased its Anavex Life Sciences (AVXL) stake by 186% in Q2 2026, buying an estimated $3.09K and bringing the position to 1,604 shares worth $4.15K. The position accounts for ﹤0.01% of the portfolio, ranked #2715.

Sterling Capital Management first reported a position in AVXL in Q3 2024 and has held it in 8 quarters since. The position peaked at $19.2K in Q4 2024. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • Sterling Capital Management held 1,604 shares of Anavex Life Sciences worth $4.15K as of Q2 2026.
  • Sterling Capital Management bought 1,043 Anavex Life Sciences shares in Q2 2026, an estimated $3.09K.
  • Anavex Life Sciences made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2715 holding.
  • Sterling Capital Management first reported a position in Anavex Life Sciences in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's Anavex Life Sciences position peaked at $19.2K in Q4 2024.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.